Overview
Status
Suspended
Registry date
2018-01-24
Share capital
5,000.00 PLN
Registered address
ul. Nowogrodzka 50/54/515, 00-695 Warszawa, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 440 days for 2022).
- 2024not filed
- 202327/09/2024
- 202227/09/2024
- 202118/01/2023
- 202025/05/2021
- 201913/11/2020
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Revenue
This companyUSD 173.98kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 12.46kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 159.43kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 8.68kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Wasim Al. Oulabi – President of the Management Board
Amrou Rabie Askar – Management Board Member
M.ayman Aziza – Management Board Member
Basseem Hussamaldin – Management Board Member
Mahmoud Farid Bathalla – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wasim Al Oulabiage 40 | 10 | $270.12 | 20% |
Amrou Mohamad Rabie Askarage 37 | 5 | $135.06 | 10% |
M.ayman Azizaage 44 | 15 | $405.19 | 30% |
Mahmoud Farid Bathallaage 58 | 15 | $405.19 | 30% |
Basseem Hussamaldinage 36 | 5 | $135.06 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2018-02-12 to 2025-12-08.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aimedicalsp. z o.o. | $240,059.72 | aimedical.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-01 | Business suspended | |
| 2023-12-22 | Address change (Ul. Nowogrodzka 50/515, 00-695, Warszawa → Ul. Nowogrodzka 50/54/515, 00-695, Warszawa) | |
| 2020-07-14 | Name change (New Horizon → Polska Medical) | |
| 2019-11-19 | PKD change (Removed: 47.91.Z, 47.99.Z, 82.92.Z; Added: 70.10.Z, 70.21.Z, 70.22.Z) | |
| 2019-07-11 | Address change (Ul. Nowogrodzka 48/8, 00-695, Warszawa → Ul. Nowogrodzka 50/515, 00-695, Warszawa) |
FAQ
The main business activity of Polska Medical focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 24, 2018.
The headquarters is located at: ul. Nowogrodzka 50/54, 00-695 Warszawa.
The management board consists of: Wasim Al. Oulabi (President of the Management Board), Amrou Mohamad Rabie Askar (Member of the Management Board), M.ayman Aziza (Member of the Management Board), Basseem Hussamaldin (Member of the Management Board), and Mahmoud Farid Bathalla (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
In 2023, the company generated total revenue of $173,976, representing an increase of 106.5% compared to 2022.
Yes, the company recorded a net profit of $12,463 in 2023.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $149,450 in 2023, representing 94% of all operating expenses.
Last updated: 2026-04-27